Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Acuson Origin cardiovascular ultrasound system and the accompanying AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
The Acuson Origin system reportedly bolsters workflow efficiency for transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) with over 5,600 artificial intelligence (AI) automated measurements, according to Siemens Healthineers, the manufacturer of the device.
The Acuson Origin ultrasound system reportedly bolsters workflow efficiency for transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) with over 5,600 artificial intelligence (AI ) automated measurements, according to Siemens Healthineers, the manufacturer of the device. (Image courtesy of Siemens Healthineers.)
AI Assist, one of the new TTE features for the Acuson Origin, provides automated positioning of color and spectral Doppler regions of interest. Offering real-time cardiac view recognition, Siemens Healthineers said the 4D HeartAI feature has a 98 percent accuracy for the identification and alignment of multiplanar reconstruction (MPR).
“With its advanced AI features and potential to enhance diagnostic accuracy as well as patient care, the Acuson Origin is positioned to reshape health care’s approach to cardiovascular imaging,” noted David Zollinger, the head of cardiovascular ultrasound at Siemens Healthineers.
Providing advanced imaging for complex heart procedures, Siemens Healthineers noted the AcuNav Lumos catheter promotes enhanced accuracy of anatomical assessments with MPR biplane imaging. The device’s real-time 4D color Doppler capabilities also facilitate improved leak detection, according to Siemens Healthineers.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.